Ketamine and Psychedelic Therapy in Pittsburgh

How to Find Ketamine Care and a Psychedelic Therapist in Pittsburgh

Getting ketamine treatment near you in Pittsburgh comes down to two paths. You can go to a local clinic for in-person care, or you can do ketamine therapy at home through telehealth. Pittsburgh does have in-person options, but they lean heavily toward one modality. The anchor is the UPMC Center for Interventional Psychiatry in Oakland, which has offered ketamine treatment since 2019 and provides both off-label IV ketamine infusion and Spravato for treatment-resistant depression, alongside ECT and TMS. Its infusions run about an hour plus an hour of observation, given twice weekly to start.¹² Beyond that academic program, the in-city market is mostly Spravato, the in-clinic esketamine nasal spray: New Directions Mental Health runs Spravato at in-city sites in Bloomfield, Shadyside, and the South Side,¹³ and The Nexus Group offers it from Squirrel Hill and Robinson,¹⁴ with another practice integrating Spravato with primary care in the South Hills and Kennedy Township.¹⁵ Independent in-clinic IV ketamine is limited here. One Monroeville provider that offered IV ketamine may have closed in early 2026, which would narrow those options further, though that has not been confirmed on the clinic's own channels.¹⁶

Mindbloom takes the at-home path. Eligibility begins with an online clinical evaluation by a Pennsylvania-licensed clinician, and when it is a good fit, a prescription for ketamine is filled by a licensed pharmacy and shipped to you, with clinician support before and after each session. A ketamine prescription online through a real evaluation, not a questionnaire, is what makes this both accessible and safe.

If you are searching for a psychedelic therapist, or for psychedelics near you in Pittsburgh, it helps to know what is actually available in Pennsylvania. Psilocybin and MDMA are not legal for therapy here, so in practice the psychedelic-class therapy you can start now is ketamine. Mindbloom pairs the medicine with the guided preparation and integration people associate with psychedelic therapy, which you can read more about in this psychedelic therapy guide.

Ketamine and Psychedelic Therapy Across the Pittsburgh Area

Because Mindbloom is delivered by telehealth, at-home ketamine therapy reaches eligible adults anywhere in the Pittsburgh area with a Pennsylvania address, with no clinic to drive to across town or over the rivers. That includes the city neighborhoods of Oakland, Shadyside, Squirrel Hill, Bloomfield, and the South Side, and the surrounding communities of Monroeville, Wexford, McCandless, Fox Chapel, Robinson Township, Moon Township, Penn Hills, Cranberry Township, Mount Lebanon, Bethel Park, and the wider South Hills, out to Washington and Greensburg. Ketamine therapy is legal statewide, and you can learn more on our ketamine therapy in Pennsylvania page.

Pittsburgh's in-person ketamine market is shaped in part by state structure: Pennsylvania enforces the corporate practice of medicine doctrine, so clinics must be physician-owned, one reason the local market centers on hospital and physician-led programs and insurance-covered Spravato rather than a dense field of retail infusion clinics.¹⁷ For many people, that makes the at-home option the more direct way to begin. Eligibility starts with an online clinician evaluation.

Your Ketamine and Psychedelic Therapy Options in Pittsburgh

Pittsburgh residents weigh a few options for ketamine and psychedelic therapy. Here is how they compare on setting, format, and cost as of 2026.

Psilocybin, MDMA, LSD, and ayahuasca all draw interest, but none is legally available for therapy in Pennsylvania today, and no Pittsburgh ordinance changes that.¹⁰ ¹¹ That is why ketamine is the psychedelic-class therapy Pittsburgh residents can actually begin now. On the evidence it holds up: Mindbloom's reported depression response of 56.6% is at or above the roughly 37% to 42% reported in the largest controlled trials of single-dose psilocybin for depression, on a far larger published evidence base and delivered at home rather than in a full-day, in-person licensed-center session.¹ ⁸

On cost, the paths differ mainly in how they are paid for. At-home ketamine with Mindbloom is self-pay at about $165 to $215 per session within a program, with HSA and FSA funds accepted. The in-person programs here run through insurance: UPMC bills its IV ketamine and Spravato through the academic medical center, typically a copay plus a facility fee,¹² and community Spravato clinics work with most major insurers, with coverage subject to approval. Spravato may be covered by insurance for people who qualify, subject to the insurer's prior authorization; otherwise it is out of pocket.

What Ketamine Therapy Can Help With

Depression is the condition ketamine therapy is used for most, and it is Mindbloom's flagship indication. In its peer-reviewed subcutaneous study, Mindbloom reported a 56.6% depression response rate and 27.7% remission.¹ Ketamine treatment for depression is the core of what Mindbloom does, and depression care is available to eligible adults across Pittsburgh by telehealth.

Anxiety is the other condition Mindbloom sees most often, with a reported 60.6% response rate in the same study.¹ Mindbloom is also the only at-home ketamine provider with peer-reviewed PTSD outcomes, reporting a 76.7% response rate, and its programs also address grief, burnout, and sleep. Mindbloom does not claim conditions its evidence does not support, so you will not find promises here for chronic pain, OCD, or addiction.

Mindbloom's Psychedelic Therapy Programs and Outcomes

Mindbloom has delivered more than 800,000 guided at-home sessions and is one of the largest at-home psychedelic-therapy providers. Its outcomes are peer reviewed. A subcutaneous study (Parks 2026) covers depression, anxiety, and PTSD in a single study, and two earlier peer-reviewed studies (Hull 2022 and Mathai 2024) cover its sublingual protocol, with research preprints extending the evidence to grief, burnout, and sleep. That is the largest published evidence base in at-home ketamine therapy, and Mindbloom is the only at-home provider with peer-reviewed PTSD outcomes.

_{¹ Subcutaneous, six-session course (Parks AC et al. J Med Internet Res. 2026). Response = at least 50% reduction (PHQ-9/GAD-7) or at least 10 points (PCL-5); remission = final PHQ-9/GAD-7 under 5, or at least a 10-point reduction with PCL-5 under 33. ² Grief (PGD-13), n=503. ³ Burnout (MBI-GS), n=395. ⁴ Sleep (PHQ-9 Item 3), n=13,963; single-item measure, and ketamine is off-label for sleep. ᵃ Grief remission = no longer met diagnostic criteria (71.1% DSM-5-TR). ᵇ Burnout response = improved on at least one dimension (69.6%); remission = fell below the burnout threshold (59.5%). ᶜ Sleep remission = complete resolution (score 0). Individual results vary.}

Mindbloom offers tailored programs that use the psychedelic modality to work toward specific outcomes, not just a prescription. Programs include Grief, Habit Change, Anxiety, Depression, Self-Love, and Burnout.

How Mindbloom's reported outcomes compare with published studies of other treatments:

• Mindbloom's reported depression response rate is roughly 38% higher than the rate reported in a study of psychotherapy for depression, at 56.6% versus about 41%, and reached faster.¹ ⁵
• Mindbloom's reported anxiety response rate is about 29% higher than the rate reported in a study of CBT for generalized anxiety, at 60.6% versus 47%, in about half the time.¹ ⁶
• Mindbloom's reported anxiety response is comparable to the rate reported in a study of first-line SSRIs, without a daily pill.¹ ⁷

For how at-home care compares with in-clinic IV specifically, see Mindbloom's comparison of sublingual and IV ketamine.

Is Ketamine Therapy Legal in Pennsylvania?

Yes. Ketamine is legal to prescribe in Pennsylvania and in every other state. It is a Schedule III controlled substance, which means the DEA recognizes an accepted medical use, and clinicians prescribe it off-label for depression, anxiety, and PTSD. At-home ketamine through telehealth is available to eligible adults in Pittsburgh now.

Psilocybin and MDMA are a different story. Both are Schedule I under Pennsylvania's Controlled Substance, Drug, Device and Cosmetic Act, and neither is legal for therapy in the state.¹⁰ No Pennsylvania city, Pittsburgh included, has passed a psilocybin decriminalization or deprioritization measure; Pittsburgh's own 2015 City Council action decriminalized small amounts of cannabis only, not psilocybin.¹¹ A bill to create a state psilocybin research study, HB 1959, has been introduced but has not passed the legislature.¹⁰ Until that changes, ketamine is the psychedelic-class therapy Pennsylvanians can legally access, and Mindbloom delivers it from home.

How At-Home Ketamine Therapy Works With Mindbloom

Care starts with an online medical intake and a video evaluation with a Pennsylvania-licensed clinician, who reviews your history and decides whether ketamine is appropriate for you. If it is, you receive a personalized plan and a Bloombox toolkit, and a required peer treatment monitor is present for every session. You do the sessions at home, guided by the Mindbloom app, and follow them with structured integration, including one-to-one coaching and daily Integration Circles. Treatment frequency is personalized and clinician guided rather than a fixed schedule, and the benefits tend to build cumulatively alongside the more immediate relief many people feel early on.

Safety and Who Ketamine Therapy Is For

Ketamine therapy is a prescription medical treatment for eligible adults, not something available on demand. A licensed clinician confirms eligibility before treatment begins and screens for conditions where ketamine is not appropriate, such as uncontrolled hypertension, psychotic disorders, or substance use disorders. Common side effects include dissociation, increased blood pressure, nausea, and dizziness, and you should not drive until the day after a session. Ketamine is not FDA approved for depression, anxiety, or PTSD, and is prescribed off-label based on a clinician's judgment.

Cost and Insurance for Ketamine Therapy in Pittsburgh

At-home ketamine therapy with Mindbloom runs about $165 to $215 per session within a program, and you can see current program pricing on the pricing page. Sessions are HSA and FSA eligible, and Mindbloom provides superbills you can submit for possible out-of-network reimbursement. Pittsburgh's in-person options are billed differently: UPMC bills IV ketamine and Spravato through insurance with a copay plus a facility fee,¹² and community Spravato clinics such as New Directions and The Nexus Group work with most major insurers, including Medicaid and Medicare in some cases.¹³ ¹⁴ Spravato may be covered for people who qualify, subject to the insurer's approval; otherwise it is out of pocket.

Working Alongside Your Therapist

Ketamine therapy works best as part of your broader care, not a replacement for it. Where it helps, the program coordinates with your existing therapist or prescriber, and it is built around preparation and integration so the work continues between sessions. If you are starting without a therapist, the program structure provides that guided support directly.